Review decisions

Showing 820 results of 2631 total
Summary Safety Review - Airvo 2 Humidifier - Assessing the Potential Risk of Breathing Problems Associated with Undetected, Accidental Disconnection of Nasal Cannula
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00280
Issued / Original Publication Date: 2022-01-25
Regulatory Decision Summary for Veklury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00954
Product Type: Drug
Control Number: 248928
Manufacturer: Gilead Sciences Canada Inc.
Submission Type: Supplement to a New Drug Submission - Confirmatory
Date Filed / Submission Date: 2021-01-29
Decision / Authorization Date: 2022-01-24
Regulatory Decision Summary for Darzalex SC
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00915
Product Type: Drug
Control Number: 249815
Manufacturer: Janssen Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-02-23
Decision / Authorization Date: 2022-01-21
Regulatory Decision Summary for Mezera
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00956
Product Type: Drug
Control Number: 247241
DIN(s): 02524481
Manufacturer: Avir Pharma Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-12-08
Decision / Authorization Date: 2022-01-18
Regulatory Decision Summary for Paxlovid
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00904
Product Type: Drug
Control Number: 259186
DIN(s): 02524031
Manufacturer: Pfizer Canada ULC., on behalf of BioNTech Manufacturing GmbH
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2021-12-01
Decision / Authorization Date: 2022-01-17
Regulatory Decision Summary for Tecentriq
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00911
Product Type: Drug
Control Number: 254361
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-06-30
Decision / Authorization Date: 2022-01-14
Regulatory Decision Summary for HyQvia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01080
Product Type: Drug
Control Number: 247727
DIN(s): 02524368, 02524376, 02524384, 02524392, 02524406
Manufacturer: Takeda Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2020-12-18
Decision / Authorization Date: 2022-01-14
Regulatory Decision Summary for Benvyon
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01083
Product Type: Drug
Control Number: 248962
DIN(s): 02524309
Manufacturer: Pfizer Canada ULC., on behalf of BioNTech Manufacturing GmbH
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-01-29
Decision / Authorization Date: 2022-01-14
Regulatory Decision Summary for Xofluza
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00953
Product Type: Drug
Control Number: 253245
DIN(s): 02524163
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-01-13
Decision / Authorization Date: 2022-01-13
Summary Safety Review - Esophageal Stents - Assessing the Potential Risk of Bilateral Vocal Cord Paralysis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00279
Issued / Original Publication Date: 2022-01-13

Displaying 811 - 820 of 2631 | Page 82 of 264
Date modified: